Doctor profile · Federal record
Dr. James Essell, MD
Hematology & Oncology Physician · Hematology & Oncology Physician · Cincinnati, OH
- NPI 1265425078
- 21 yrs on file
- Licensed in 2 states
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
4777 E Galbraith RD, Ste 320
Cincinnati, OH 452362725
(513) 751-2273
fax (513) 793-6290 - Mailing address
-
5053 Wooster RD
Cincinnati, OH 452262326
Credentials & registration
- NPI registered
- August 2005 — 21 yrs on file
- Profile last updated
- April 22, 2021
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (2)
- Ohio #35056219 · Kentucky #33625
- Medicaid (3)
- OH #0970249 · KY #64935398 · IN #200088560
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1265425078. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
33,979
Distinct HCPCS
10
Medicare allowed
$603,801
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5101 |
Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram | 10,320 | 11 | $0 | |
J1568 |
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 5,300 | 34 | $43 | |
J0894 |
Injection, decitabine, 1 mg | 3,800 | 12 | $2 | |
Q5119 |
Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 3,610 | 20 | $27 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 2,659 | 51 | $0 | |
J1626 |
Injection, granisetron hydrochloride, 100 mcg | 1,720 | 25 | $0 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 1,054 | 279 | $8 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 834 | 218 | $121 | |
80053 |
Blood test, comprehensive group of blood chemicals | 800 | 236 | $10 | |
82784 |
Gammaglobulin (immune system protein) measurement | 445 | 77 | $9 |
In context: peer comparison
Among 24 peers in Cincinnati Hematology & Oncology Physician, average services per provider: 983. This provider delivers 35× the peer median.Open Payments
Industry payments received
All-time total
$52,357
Transactions
41
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Abbvie INC. | 16 | $18,285.79 | |
| Genmab U.S., INC. | 8 | $16,662.28 | |
| Kite Pharma, INC. | 2 | $7,950.00 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $3,528.50 | |
| Incyte Corporation | 1 | $1,925.00 | |
| Celgene Corporation | 5 | $1,500.00 | |
| Janssen Scientific Affairs, LLC | 1 | $1,470.00 | |
| Janssen Biotech, INC. | 1 | $781.25 | |
| Pfizer INC. | 1 | $150.00 | |
| Legend Biotech USA INC. | 1 | $65.49 | |
| Servier Pharmaceuticals LLC | 1 | $24.73 | |
| Genzyme Corporation | 1 | $13.56 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,240
Patients
178
Total drug cost
$4,967,959
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Valacyclovir (Valacyclovir Hcl) | Brand | 185 | 34 | $10,812 |
| Penicillin V Potassium | Generic | 162 | 26 | $2,565 |
| Acyclovir | Generic | 134 | 30 | $2,414 |
| Eliquis (Apixaban) | Brand | 102 | 14 | $69,295 |
| Calquence (Acalabrutinib Maleate) | Brand | 75 | 0 | $1,030,121 |
| Fluconazole | Generic | 74 | 18 | $4,352 |
| Jakafi (Ruxolitinib Phosphate) | Brand | 74 | 0 | $1,250,835 |
| Revlimid (Lenalidomide) | Brand | 64 | 0 | $1,135,831 |
| Warfarin Sodium | Generic | 64 | 12 | $737 |
| Imbruvica (Ibrutinib) | Brand | 63 | 0 | $1,036,015 |
Frequently asked questions
What is Dr. James Essell's medical specialty?
Dr. James Essell practices Hematology & Oncology Physician in Cincinnati, OH.
Where does Dr. James Essell practice?
Dr. James Essell practices at 4777 E Galbraith RD, Cincinnati, OH 452362725. Office phone: 5137512273.
What is Dr. James Essell's NPI?
Dr. James Essell's National Provider Identifier (NPI) is 1265425078, issued by NPPES.
What procedures does Dr. James Essell commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram (HCPCS Q5101); Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS J1568); Injection, decitabine, 1 mg (HCPCS J0894). Source: CMS Medicare Physician & Other Practitioners file.